Research Highlights

We're leading the way in discovering new and innovative approaches to dramatically reduce the burden of cardiovascular disease.
See our research areas

Stopping atherosclerosis in its tracks

Stopping atherosclerosis in its tracks
A new treatment for atherosclerosis could soon be in sight, with an HRI study finding that progression of the common condition could be slowed using the chemokine binding protein ‘M3’.
Read more

Meet the team: Zohra Kakall

Meet the team: Zohra Kakall

PhD student Zohra Kakall has always been fascinated by whole body physiology and the integration between the brain and other bodily systems. This fascination drew her to the HRI High Blood Pressure Group - which focuses on the way that brain networks control airways, breathing and blood pressure - and led her on a research trip across Europe.

Read more

It's about time

It's about time
Every year, National Diabetes Week raises awareness of diabetes and how it affects Australians. It’s about time we did a better job of detecting all types of diabetes. That’s why the HRI is conducting several research projects around detection, prevention and treatment, that are relevant to both diabetes and heart disease. 
Read more

Dr Anna Waterhouse joins HRI as Group Leader

Dr Anna Waterhouse joins HRI as Group Leader

The HRI is pleased to welcome Dr Anna Waterhouse as Group Leader of the Cardiovascular Medical Devices Group and Senior Lecturer at the University of Sydney. Dr Waterhouse’s research focuses on how medical devices – such as artificial hearts, stents and bypass machines – interact with the body. Her aim is to understand the interactions of medical devices with patients’ blood, proteins and cells to develop more sophisticated and compatible materials. 

Read more

A new generation of blood vessels?

A new generation of blood vessels?
The HRI’s Applied Materials Group is working to develop the next generation of bioactive materials – materials that can bond to living tissues.
Read more